1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Sonova Holding AG

Sonova Holding AG

SONVF
Sonova Holding AGUS flagOther OTC
275.60
USD
- -
- -
16.37BMarket Cap
Sonova Holding AG
SONVF
(Other OTC)

Recent

price

275.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
121.56
121.02
133.76
28.88
30.14
31.21
36.43
40.24
42.19
45.62
41.32
54.02
62.07
60.82
60.62
60.53
Revenue per Share
17.37
18.44
8.18
5.04
5.33
5.08
5.31
6.08
6.93
7.56
9.23
10.42
10.75
10.08
9.07
7.23
Basic EPS, GAAP
17.52
16.75
22.71
4.68
5.49
5.2
6.45
7.96
8.14
11.18
10.72
13.4
10.45
10.48
11.05
10.61
Free Cash Flow per Basic Share
5.97
5.97
5.95
1.59
1.89
2.05
2.09
2.29
2.59
2.92
- -
3.24
4.44
4.6
4.3
4.4
Dividend per Share
92.12
110.3
119.47
25.76
28.38
30.7
32.25
37.29
38.49
38.46
48.51
50.29
43.86
41.49
44.8
44.64
Book Value per Share
21.48
26.91
32.89
9.08
9.66
8.38
-2.92
0.13
-1.33
-6.11
5.57
-8.29
-13.73
-9.18
-5.03
0.25
Tangible Book Value per Share
13
13
13
68
68
66
66
66
66
64
63
62
60
60
60
60
Basic Weighted Avg Shares
1,617
1,620
1,795
1,951
2,035
2,072
2,396
2,646
2,763
2,917
2,602
3,364
3,738
3,627
3,613
3,606
Sales/Revenue/Turnover
18.95
18.22
8.66
20.71
21.08
19.05
17.69
18.05
19.39
17.48
19.03
22.6
19.98
18.47
19.92
18.74
Operating Margin (%)
103
78
82
83
85
89
147
135
128
200
223
211
240
246
233
260
Depreciation Expense
231
247
110
341
360
337
349
400
454
483
581
649
648
601
540
431
Net Income, GAAP
11.16
12.55
25.32
11.96
12.37
12.9
14.65
14.93
13.1
2.57
2.53
8.86
8.02
5.84
17.45
14.91
Effective Tax Rate (%)
14.29
15.23
6.11
17.47
17.69
16.27
14.58
15.12
16.43
16.57
22.33
19.29
17.32
16.57
14.96
11.94
Profit Margin (%)
278
341
615
507
569
499
532
582
282
118
1,368
154
409
514
411
895
Working Capital
228
242
229
- -
- -
- -
759
609
360
767
1,410
1,080
1,736
1,715
1,328
1,525
LT Debt
1,345
1,481
1,641
1,774
1,872
1,906
2,131
2,475
2,376
2,029
2,772
2,433
2,231
2,491
2,685
2,636
Total Equity
15.77
14.84
6.26
18.75
19.59
17.53
14.58
12.85
14.48
15.83
12.23
15.81
16.65
14.57
13.11
12.73
Return on Invested Capital (%)
14.48
15.6
6.29
18.38
18.68
16.45
13.84
12.85
14.09
14.46
14.06
13.69
14.45
14.13
12.73
10.09
Return on Capital (%)
18.91
18.27
7.13
20.38
19.69
17.05
16.79
17.5
18.26
19.41
21.08
20.98
22.43
23.5
21.01
16.16
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.3%
-0.59%
-1.81%
Free Cash Flow
7.62%
-0.08%
-4.07%
Net Income, GAAP
3.22%
-5.22%
-20.33%
Sales/Revenue/Turnover
6.21%
7.37%
-0.19%
Total Cash Common Dividend
10,066.44%
20,146.2%
2.38%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3,627
2025
- -
- -
- -
- -
3,613
2026
- -
- -
- -
- -
3,606

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10.08
2025
- -
- -
- -
- -
9.07
2026
- -
- -
- -
- -
7.23

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.6
2025
- -
- -
- -
- -
4.3
2026
- -
- -
- -
- -
4.4
Similar Companies
Codex DNA, Inc. (DNAY)
Avisa Diagnostics Inc. (AVBT.CN)
Owlet, Inc. (OWLT)
ProSomnus, Inc. (OSAPQ)
Drägerwerk AG & Co. KGaA (DRW3.DE)
Co-Diagnostics, Inc. (CODX)
Business
Sonova Holding AG is a global leader in innovative hearing care solutions, headquartered in Stäfa, Switzerland, and founded in 1947. The company operates through four primary business segments: Hearing Instruments, Audiological Care, Consumer Hearing, and Cochlear Implants. Its main products include advanced hearing aids under flagship brands Phonak and Unitron, cochlear implants through its Advanced Bionics brand, personal audio devices, wireless communication systems, and professional audiological care services delivered via a network of more than 3,600 clinics in over 20 countries under the AudioNova and other regional brands. Sonova also manages the Sennheiser consumer hearing business under license, expanding its portfolio in personal audio devices and wireless technologies. The company's latest major developments include the launch of the Phonak Infinio and Sphere Infinio hearing aid platforms in August 2024, which introduce new proprietary chips combining real-time processing with artificial intelligence for superior sound quality and speech separation in noisy environments. Sonova continues expanding its Audiological Care network with bolt-on acquisitions mainly in Australia, Canada, and Germany, investing in digital tools and new product innovations to enhance hearing health globally. In 2025, Eric Bernard succeeded as CEO, emphasizing innovation and market expansion. Sonova's strategic acquisitions, such as the integration of the Sennheiser consumer division in 2021, bolster its position in the growing markets for hearables, true wireless, and audiophile headphones. Operating in over 100 countries, Sonova serves a broad consumer base, addressing the needs of individuals with hearing loss, healthcare professionals, and consumers seeking advanced audiological and personal audio technologies. The company maintains its commitment to continuous innovation and market leadership through its diversified product offerings and global distribution channels, reinforcing its vision of a world where everyone enjoys the delight of hearing. Sonova’s significant brands include Phonak, Unitron, Advanced Bionics, AudioNova, and Sennheiser consumer hearing, positioning it as a comprehensive provider in the hearing care industry.

Company News

APIChat

  • seekingalpha.com

    Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript

  • seekingalpha.com

    Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript

  • reuters.com

    Sonova expects FY revenue at lower end of target range, CEO says in interview

  • seekingalpha.com

    Sonova Holding AG (SONVY) Q2 2026 Earnings Call Transcript

  • seekingalpha.com

    Sonova Holding AG (SONVF) Q4 2025 Earnings Call Transcript

  • wsj.com

    Sonova Shares Jump on Sales Beat, CEO Change

  • seekingalpha.com

    Sonova Holding AG (SONVF) Q2 2025 Earnings Call Transcript